Dr. Martine Dehlinger-Kremer has 30 years of experience in the research industry including 28 years of progressively higher levels of Regulatory, Medical Affairs and Pediatric leadership responsibility.

Dr. Martine Dehlinger-Kremer has contributed to global development of numerous products, including orphan drugs and biosimilars. She has participated in 100+ New Drug Applications and Marketing Authorization Applications globally and in clinical studies across all phases.

She is an observer Member of the Coordinating Group of Enpr-EMA, the European Network of Pediatric Research at the European Medicines Agency (EMA) and since many years a member of Working Parties of Enpr-EMA. She is Chair of the Pediatric Working Group of EUCROF since 2008, Chair of the European Forum for GCP (EFGCP) Children Medicines Working Party. Martine is also a member of the External Advisory Board of iCAN, the International Children’s Advisory Network.

Since 2016, Dr. Martine Dehlinger-Kremer is President of EUCROF, the European CRO Federation.

Dr Dehlinger-Kremer was Named One of PharmaVOICE 100’s Most Inspiring People in Life Sciences (Industry leader recognized for impact, experience and advocacy in clinical research) in August 2015.

Dr. Dehlinger-Kremer holds a Doctorate in Sciences, a Master of Advanced Study in Neurophysiology degree, and a Master of Science degree.